Company / Revenue
Harmony Biosciences Holdings, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$868.5M
FY2025
5-year range
$6.0M / $868.5M
FY2021-FY2025
Trend
+21.5%
vs FY2024
Sector context
#45 of 155
Health Care
What the data says
At $868M, Harmony Biosciences Holdings, Inc.'s revenue ranks #45 of 155 in the Health Care sector. Revenue has increased for 4 consecutive years, from $6M in FY2021 to $868M in FY2025.
Based on SEC 10-K filings.
$868M in FY2025 with a 5-year CAGR of +170.5%.
Improved from $582M to $868M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +25.6%
- 5-Year CAGR
- +170.5%
- 10-Year CAGR
- -
Sector benchmark
#45 of 155 in Health CareTop 29% of 155This company $868.5M Sector average $4.5B
▼
-80.6% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s revenue has grown for 4 consecutive years.
- 5-year CAGR of +170.5%, indicating consistent growth.
- In FY2025, revenue increased 21.5% year-over-year.
- Ranks #45 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $868.5M | +21.5% |
| FY2024 | $714.7M | +22.8% |
| FY2023 | $582.0M | +32.9% |
| FY2022 | $437.9M | +7203.7% |
| FY2021 | $6.0M | +0.0% |
| FY2020 | $6.0M | +0.0% |
| FY2019 | $6.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026